Display options
Cite
Harnoor A, West RL, Cook FJ. Feminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia. Case Rep Endocrinol. 2012;2012:760134doi: 10.1155/2012/760134.
Harnoor, A., West, R. L., & Cook, F. J. (2012). Feminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia. Case reports in endocrinology, 2012760134. https://doi.org/10.1155/2012/760134
Harnoor, Anjana, et al. "Feminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia." Case reports in endocrinology vol. 2012 (2012): 760134. doi: https://doi.org/10.1155/2012/760134
Harnoor A, West RL, Cook FJ. Feminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia. Case Rep Endocrinol. 2012;2012:760134. doi: 10.1155/2012/760134. Epub 2012 Jun 26. PMID: 22937299; PMCID: PMC3420512.
Copy Download .nbib Format: NLM
Share it on

Case Rep Endocrinol. 2012;2012:760134. doi: 10.1155/2012/760134. Epub 2012 Jun 26.

Feminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia.

Case reports in endocrinology

Anjana Harnoor, R Lee West, Fiona J Cook

Affiliations

  1. Division of Endocrinology, Department of Internal Medicine and The Department of Pathology, Brody School of Medicine at East Carolina University, Greenville, NC 27834, USA.

PMID: 22937299 PMCID: PMC3420512 DOI: 10.1155/2012/760134

Abstract

We present a case of feminizing adrenal carcinoma with severe elevation in serum estradiol and otherwise unexplained congestive heart failure with ventricular arrhythmia and review the literature on feminizing adrenal tumors and the potential relationship between estrogen and cardiac problems. A 54-year-old man presented with congestive heart failure and ventricular arrhythmia. Imaging revealed a large adrenal mass. Hormonal evaluation revealed a very high serum level of estradiol, elevated DHEA-sulfate and androstenedione, and lack of cortisol suppression on a low-dose overnight dexamethasone suppression test. The patient underwent a left adrenalectomy with subsequent normalization of serum estradiol. Surgical pathology examination established adrenocortical carcinoma MacFarlane stage II. Upon 15-month followup, the patient continued to have a normal serum estradiol level, his cardiac function was significantly improved, and he had no further episodes of ventricular arrhythmia. To the best of our knowledge, the serum estradiol level that was detected in our case is the highest that has been reported. Further, we hypothesize that the very high serum concentration of estradiol in our case may have played a role in his cardiac presentation with congestive heart failure and arrhythmia, particularly as these problems resolved with normalization of his serum estradiol level.

References

  1. PLoS Comput Biol. 2010 Jan 29;6(1):e1000658 - PubMed
  2. JAMA. 2009 May 13;301(18):1892-901 - PubMed
  3. Exp Physiol. 2008 Aug;93(8):982-93 - PubMed
  4. J Cardiovasc Electrophysiol. 1999 Apr;10(4):587-98 - PubMed
  5. J Am Med Assoc. 1953 Jul 18;152(12):1135-41 - PubMed
  6. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  7. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  8. Postgrad Med J. 1962 Mar;38:165-7 - PubMed
  9. Pharmacol Ther. 2010 Jul;127(1):9-18 - PubMed
  10. Congest Heart Fail. 2010 Mar-Apr;16(2):77-9 - PubMed
  11. Ann Endocrinol (Paris). 2006 Mar;67(1):32-8 - PubMed
  12. Ann Noninvasive Electrocardiol. 2004 Oct;9(4):366-74 - PubMed
  13. J Cardiovasc Electrophysiol. 2011 Mar;22(3):332-3 - PubMed
  14. Surg Clin North Am. 2009 Oct;89(5):1255-67 - PubMed
  15. Am J Med Sci. 2009 Sep;338(3):252-3 - PubMed

Publication Types